arrow
H

Holden T. Maecker

stanford medicine
H指数:84
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Virus reactivation in acute and long COVID-19

急性期与长期新型冠状病毒肺炎中的病毒再激活

Nature
IF48.5
2026-08-050
OA
Human vaccine responses regulated by parallel cytokine pathways

人用疫苗应答由平行的细胞因子通路调控

2026-06-120
OAAI
Early immune events during SARS-CoV-2 infection impact memory T and B cell responses

SARS-CoV-2感染早期的免疫事件影响记忆T和B细胞反应

2026-06-050
OAAI
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19

经验性阿奇霉素改变了COVID-19患者上呼吸道微生物组和耐药组,但无抗炎益处。

2026-03-160
OAAI
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

作者更正:机器学习模型根据基线临床和免疫学因素预测长新冠结局

2026-02-230
OAAI
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors

机器学习模型根据基线临床和免疫学因素预测长新冠结局。

2026-01-030
OAAI
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum

联合使用芦可替尼可减轻炎症并增强免疫力,在实验性感染恶性疟原虫的志愿者中。

2025-11-260
OAAI
Minimalistictranscriptomic signatures permit accurate early prediction of COVID-19 mortality

极简转录组学特征能够实现COVID-19死亡率的准确早期预测

2025-11-100
PRE
Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness

花生过敏口服免疫疗法驱动与持续无反应性相关的花生反应性T细胞的单细胞多体变化

2025-11-040
OAAI
A multiomics recovery factor predicts long COVID in the IMPACC study

多组学恢复因子预测IMPACC研究中的长期COVID

2025-11-030
OA